Researchers develop a method to select eggs with the best chance of leading to successful pregnancy

Mar 12, 2008

A research team supervised by Université Laval scientist Marc-André Sirard has identified genetic markers that allow the selection of eggs with the best chance of leading to successful pregnancy after in vitro fertilization (IVF). This finding could both increase the success rate of single embryo transfer and diminish the risk of multiple pregnancies. The details of the method developed by the researchers, for which an international patent application has been filed, are explained on the website of the scientific journal Human Reproduction.

Eggs recovered in the course of the IVF process are surrounded by follicular cells that are removed before the actual fertilization procedure begins. “While in the ovaries, these cells and the eggs are in very close interaction,” explains Sirard. “A first experiment we conducted on bovine follicular cells led us to believe that these cells might possess specific markers that would be able to give us information about the quality of an egg.”

With the help of 40 women recruited in a fertility clinic, researchers compared follicular cells surrounding eggs that ultimately led to successful pregnancies—i.e. “good” eggs—to cells surrounding ovules that did not result in pregnancy. This comparison led to the identification of five genes expressed more abundantly in follicular cells surrounding good eggs.

Currently, the way to assess which embryos are to be transferred into a woman’s uterus is based on visible criteria such as appearance and division rate. “At least 30% of embryos that look normal through visual examination nonetheless show chromosome abnormalities,” explains Professor Sirard, illustrating the limits of this type of assessment. The method developed by Sirard’s team makes it possible to objectively select ovules that have the best chance of success without altering the integrity of the embryos.

This new genomic tool could also solve an ethical problem confronting both fertility clinic doctors and the people who consult them: In order to increase the chances of pregnancy, many embryos are implanted simultaneously into the woman in the hope that at least one will survive. This procedure along with improved IVF techniques has led to an increase in multiple pregnancies.

Even if doctors now tend to transfer fewer embryos, multiple pregnancies still occur in 30% of couples who resort to IVF in North America and 23% in European couples. “By selecting the embryo with the best potential, it would be possible to limit the number of embryos transferred, and thus the number of multiple pregnancies, while maintaining good success rates,” concludes Marc-André Sirard.

Source: Université Laval

Explore further: Court clears German safety body in breast implant scare

Related Stories

How frogs and fish can help us learn to freeze humans

Jun 03, 2015

From Star Wars to Futurama to Alien, the idea that humans can be frozen in time in order to be awoken later is a well-established sci-fi trope. While stopping biological time or inducing long-term hibernation ...

Scientists turn stem cells into precursors for sperm, eggs

Oct 28, 2009

Human embryonic stem cells derived from excess IVF embryos may help scientists unlock the mysteries of infertility for other couples struggling to conceive, according to new research from the Stanford University School of ...

Stem cell lines created from discarded IVF embryos

Feb 05, 2008

Human embryos that are discarded every day as medical waste from in vitro fertilization (IVF) clinics could be an important source of stem cells for research, according to a team of Harvard Stem Cell Institute researchers ...

New method increases supply of embryonic stem cells

Jan 27, 2014

A new method allows for large-scale generation of human embryonic stem cells of high clinical quality. It also allows for production of such cells without destroying any human embryos. The discovery is a big step forward ...

Recommended for you

Drug and device firms paid $6.5B to care providers

Jun 30, 2015

From research dollars to free lunches and junkets, drug and medical device companies paid doctors and leading hospitals nearly $6.5 billion last year, according to government data posted Tuesday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.